Smell loss (hyposmia)
Olfactory dysfunction as prodromal marker and clinical symptom; smell-training evidence.
State of the art
No update yet for Smell loss (hyposmia). An update is a standalone state-of-the-art for the topic — what someone with Parkinson's needs to know about where this approach stands today.
-
With new FDA green light for developer, Parkinson’s clinical trial to launch soon
In an ongoing Phase 1b extension study, GT-02287 treatment was associated with improvement in sense of smell alongside gait and sleep, in people with Parkinson's disease.